Patients sue GLP-1 makers over sudden loss of vision
Patients are suing major pharmaceutical companies, including Novo Nordisk and Eli Lilly, claiming that their GLP-1 weight-loss drugs caused sudden vision loss. The patients say the companies did not adequately warn them about the risk of a rare condition that leads to vision loss. One patient, Diane Wirth, lost vision in one eye after taking Wegovy, a GLP-1 drug. The lawsuits are now underway with hundreds of patients involved.
17 across the spectrum. Choose a side on the bar to jump to it.
National story. 50 articles from 18 sources. 17 are on the bar; 1 is an international, entertainment or tech outlet, listed separately. Updated Sep 25, 2026.
The story so far
2 developments- Sep 22Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION
- Sep 23GLP-1 drugmakers are being sued by patients who suddenly lost their vision
Who covered each development
No new developments
Quiet for 48 daysLast development · Sep 23 — GLP-1 drugmakers are being sued by patients who suddenly lost their vision
Left
2 sourcesGLP-1 drugmakers are being sued by patients who suddenly lost their vision
Could GLP-1s be linked to a rare type of vision loss? Here’s what to know.
Center
13 sourcesRight
2 sourcesOther outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 articleCenter
0 articlesNone
Right
0 articlesNone
The bigger story
This story is one of several related ones. Here's where it sits.